Harleystreet Pharmaceuticals Ltd Stock Analysis

BSE: 524082 | NSE: | Pharmaceuticals & Drugs | Small Cap

BSE Share Price
Not Listed

DeciZen - Make an Informed Decision on Harleystreet Pharma

M-Cap below 100cr DeciZen not available

FAQ's

1. Is Harleystreet Pharmaceuticals Ltd. a good quality company?

Data is not available for this company.

2. Is Harleystreet Pharmaceuticals Ltd. undervalued or overvalued?

No data found

3. Is Harleystreet Pharmaceuticals Ltd. a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Harleystreet Pharmaceuticals Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Harleystreet Pharma:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide
Mar'01Mar'02Mar'03Mar'04Mar'05Mar'06Mar'07Mar'08Mar'09Mar'10TTM
ROCE % 7.5%14%-15.1%30.8%14%23.9%19.8%11.5%12.9%16.5%-

Growth Parameters

Growth Parameters Colour Code Guide
Sales 2.71.40.40.80.70.810.94.55.76
YoY Gr. Rt. %--49.5%-74.6%114.3%-4%15.3%20.5%-13%417.2%26.2%-
Adj EPS 0.51-1.74.62.965.53.23.65.66.5
YoY Gr. Rt. %-96.2%-258.7%NA-36.6%104.8%-8.6%-41.1%12.5%54.3%-
BVPS (₹) 7.17.25.710.313.319.224.727.931.63642.4
Adj Net Profit 0.10.1-0.20.40.30.60.50.30.30.51
Cash Flow from Ops. -0.10.2100.91.10.91.10.80.2-
Debt/CF from Ops. -0.30.20.5-163.71.70.70.80.400-

CAGR

CAGR Colour Code Guide
9 Years 5 Years 3 Years 1 Years
Sales 8.5%51.2%78.4%26.2%
Adj EPS 29.9%13.9%0.7%54.3%
BVPS 19.822.113.414
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide
Mar'01Mar'02Mar'03Mar'04Mar'05Mar'06Mar'07Mar'08Mar'09Mar'10TTM
Return on Equity % 7.814.6-25.557.124.736.724.812.212.116.516.5
Op. Profit Mgn % 5.215.5-240.3-187.9-195.5-200.2-174.6-212.421.920.421.5
Net Profit Mgn % 1.97.2-44.35838.668.352357.69.39.9
Debt to Equity 000.91.51.20.40.30.200-
Working Cap Days 6181255125167110171270851010
Cash Conv. Cycle -153244-372922774-22-70

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to %

Sales growth has been subdued in last 3 years %

Net Profit has been subdued in last 3 years %

Sales growth is not so good in last 4 quarters at %

Latest Financials - Harleystreet Pharmaceuticals Ltd.

Standalone Consolidated
TTM EPS (₹) 6.5 -
TTM Sales (₹ Cr.) 6.2 -
BVPS (₹.) 42.4 -
Reserves (₹ Cr.) 3 -
P/BV 0.64 -
PE 4.17 -
From the Market
52 Week Low / High (₹) 27.00 / 27.00
All Time Low / High (₹) 9.98 / 39.95
Market Cap (₹ Cr.) 2.6
Equity (₹ Cr.) 1
Face Value (₹) 10
Industry PE 38.4

Management X-Ray of Harleystreet Pharma :

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Analyst's Notes

News

About Harleystreet Pharmaceuticals Ltd

Harleystreet Pharmaceuticals Limited was incorporated in1982 and has its registered office at Plot No.142 AB, Kandivli Industrial Estate, Kandivli (West) Mumbai Maharashtra.

Business profile:

The company is engaged in the manufacture and sale of pharmaceuticals in India. It provides formulations of ondansetron. The company offers its products in various forms, including tablets, capsules, liquids, and vials/ampoules.

Read More Read Less